TAO SHEN to Drug Resistance, Neoplasm
This is a "connection" page, showing publications TAO SHEN has written about Drug Resistance, Neoplasm.
Connection Strength
0.049
-
Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib. J Biol Chem. 2019 07 05; 294(27):10428-10437.
Score: 0.027
-
Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK. Biochem Pharmacol. 2016 09 15; 116:39-50.
Score: 0.022